Checkmate Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $61,470,000.
Profit Margin
| 2018 | 0 | -20.81M | |
|---|---|---|---|
| 2019 | 0 | -28.29M | |
| 2020 | 0 | -36.90M | |
| 2021 | 0 | -61.40M |
CMPI Income Statement (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 45.81M | 26.71M | 24.25M | 18.17M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 61.47M | 36.90M | 28.88M | 20.99M |
Operating income | -61.40M | -36.90M | -28.88M | -20.99M |
Other income (expenses), net | 0 | -4K | 597K | 180K |
Income before tax | -61.40M | -36.90M | -28.29M | -20.81M |
Income tax expense | 0 | -4K | 0 | 0 |
Net income | -61.40M | -36.90M | -28.29M | -20.81M |
Earnings per share | ||||
Basic EPS | -6.42 | -3.86 | -3.44 | -2.53 |
Diluted EPS | -6.42 | -3.86 | -3.44 | -2.53 |
| Data source | Data source |